Navigation Links
Laser Energetics Receives a $550,000 Order for a Dental Laser System
Date:1/29/2008

MERCERVILLE, N.J., Jan. 29 /PRNewswire-FirstCall/ -- Laser Energetics, Inc. (Pink Sheets: LNGT) announced today that it has received an order for a fully developed, pre-production clinical laser system with an order value of $550,000. The laser system is based on Laser Energetics' proprietary and patent protected BrightStar(TM) Alexandrite laser.

The order was placed by Hygenilase, Inc. Hygenilase is a newly-formed joint venture between Laser Energetics and Lantis Laser, Inc. of Denville, NJ (Pink Sheets: LLSR). Hygenilase, will market Laser Energetics' BrightStar(TM) Alexandrite laser for the dental application of cleaning teeth below and above the gum line. Hygenilase, Inc. is owned equally by Laser Energetics, Inc. and Lantis Laser, Inc.

Previously, Laser Energetics received an order from the joint venture for an Alexandrite development laser, and a cost-to-manufacture study to evaluate the cost of manufacturing the new compact Alexandrite laser for a specification needed to address the dental market. The study was successfully completed.

Robert D. Battis, Chairman and Chief Executive Officer of Laser Energetics, said, "We intend to use this Joint Venture transaction as a model for future business relationships with other companies in different medical laser market segments. Upon formation of new joint ventures, we will receive cash up front for the design and manufacture, and share in the profits generated with our partners' sales and marketing expertise in the particular market they serve."

Battis continued, "In this Joint Venture our goal is to take LEI's expertise in Alexandrite lasers and combine it with the expertise that Lantis Laser has in the field of dentistry. It is estimated that there are 100,000 dental offices in the US, and another 100,000 offices in Europe, Japan and other first world countries. Our expectation is that we will be selling BrightStar(TM) into this market at a price that is highly competitive and pr
'/>"/>

SOURCE Laser Energetics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Laser blasts viruses in blood
2. Skin Cooling After Laser Treatment Could Leave Marks
3. Prize for Cutting-Edge Laser Innovations
4. VNUS Medicals Patent Lawsuit Against Laser Competitors to Proceed to Trial
5. OmniGuide Announces Launch of LightPath(TM) CO2 Laser Fiber
6. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
7. Alma Lasers Answers Lumenis Complaint
8. Laser Energetics Delivers BrightStar(TM) Alexandrite Laser to Fortune 50 Defense Company
9. BioHorizons Introduces Its New Tapered Internal Implants Featuring Laser-Lok(R) Microgrooves
10. Imaging Diagnostic Systems to Present Laser Breast Imaging Clinical Results at the 2007 Radiological Society of North America Scientific Assembly
11. Low-level Laser Therapy Clinics Partnership Targets Helping People Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... For many busy people, having their missing or ... of recovery from dental surgery that have traditionally been required ... of their youthful appearance. , But the dental implant ... and Woodland Hills, Calif., can provide someone with a full ... where the patient’s bone has deteriorated. , Dr. Saj Jivraj ...
(Date:11/21/2014)... OR (PRWEB) November 21, 2014 Even with ... always something to learn and room for growth, participating in ... returned from State Farm’s National Convention, a networking event with ... around the country, bringing back the latest and greatest in ... may have spotted Kirk and his team (Stacy, Anthony, Reina ...
(Date:11/21/2014)... West Palm Beach, FL (PRWEB) November 21, 2014 ... Administration report issued on June 11th, 2014, ... Takata Corporation can rupture when the airbag inflates. The ... break into metal shrapnel, and the metal shards may ... anyone within the vehicle’s cabin. , According to ...
(Date:11/21/2014)... HealthDay Reporter THURSDAY, Nov. 20, ... may help preserve thinking skills and memory as workers ... compared IQ scores obtained around age 11 from more ... scores around age 70. The scientists found that those ... thinking even years after retirement. Researchers from ...
(Date:11/21/2014)... 20, 2014 (HealthDay News) -- While levels of testosterone ... women,s sex lives, their emotional health and quality of ... new study. Testosterone is the main sex hormone ... amounts of the hormone, the researchers noted. The ... taking part in a long-term study of women,s health. ...
Breaking Medicine News(10 mins):Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 2Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 3Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 4Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 5Health News:Kirk Martin Insurance Agency Goes Local and National with State Farm 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 3Health News:Could Your Job Help Preserve Your Aging Brain? 2Health News:Could Your Job Help Preserve Your Aging Brain? 3Health News:Testosterone Plays Minor Role in Older Women's Sex Lives, Study Finds 2
... , , SAN FRANCISCO, July 31 ... announced the execution of a letter of intent (LOI) to collaborate ... diagnostic testing and banking of advanced-stage Lung Cancer tissues. ... ) , , Specific molecular features ...
... times more likely to have chronic health conditions, less ... lower incomes than their siblings, according to a study ... the National Cancer Institute . This study was ... for neuroblastoma survivors. Caroline Laverdiere, M.D., of the ...
... , TITUSVILLE, N.J., July 31 The ... palmitate) extended-release injectable suspension for the acute and maintenance treatment ... injectable atypical antipsychotic approved in the U.S. for this use. ... in the U.S. , , An estimated ...
... health conditions are spread, study finds , FRIDAY, July 31 ... surgery doesn,t appear to increase one,s chances of having long-term ... study of 1,062 people who required a transfusion before, during ... of the patients were still alive a decade after the ...
... , GAINESVILLE, Fla., July 31 ... correction of facial wrinkles in healthy patients in the USA. It ... Surgeon, has 7 years of experience with the product while abroad. ... , Sanofi-aventis is a leading global pharmaceutical company. The ...
... 31 In a post-recession America, even though as a nation income ... crushing burden of health care costs and will watch their standards of ... the New England Journal of Medicine (NEJM) by Daniel ... University of Pennsylvania,s Leonard Davis Institute of Health Economics. , ...
Cached Medicine News:Health News:Addario Lung Cancer Medical Institute Announces Diagnostic Screening and Clinical Research Collaborations With Response Genetics, Inc. 2Health News:Addario Lung Cancer Medical Institute Announces Diagnostic Screening and Clinical Research Collaborations With Response Genetics, Inc. 3Health News:Addario Lung Cancer Medical Institute Announces Diagnostic Screening and Clinical Research Collaborations With Response Genetics, Inc. 4Health News:Long-term health and social outcomes for neuroblastoma survivors 2Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 2Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 3Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 4Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 5Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 6Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 7Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 8Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 9Health News:Post-Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families, PENN Analysis Shows 2Health News:Post-Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families, PENN Analysis Shows 3Health News:Post-Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families, PENN Analysis Shows 4
(Date:11/21/2014)... NEW YORK , Nov. 20, 2014  Market research ... as the "Year of The Buy, in the medical ... market for medical devices will produce just 3% growth ... competitive actions, including acquisitions of product lines and entrance ... an annual survey of medical devices, The Global ...
(Date:11/21/2014)... QC , Nov. 20, 2014 /CNW Telbec/ - ... to announce the following appointments: ... team in the newly created role of Chief Commercial ... BioPhotonic system using topical photoconverter gel for the treatment ... surgical and traumatic wounds, recently approved in ...
(Date:11/21/2014)... Calif. , Nov. 20, 2014 Depomed, Inc. (NASDAQ: ... at the Piper Jaffray 26 th Annual Healthcare Conference in ... at the Piper Jaffray conference is scheduled for 8:00 am EST ... be webcast, and the webcast can be accessed via the Investor ... recording of the webcast will be archived for 30 days on ...
Breaking Medicine Technology:Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference 2
... DIEGO, May 12, 2011 GT Life Sciences, Inc., ... issuance of Patent No. 7,856,317 for "SYSTEMS AND METHODS ... Patent and Trademark Office.  The ,317 patent has a ... novel claims to computer systems and complex modeling processes ...
... Reportlinker.com announces that a new ... its catalogue: Generic ... Focus on Super Generics and Biosimilars ... http://www.reportlinker.com/p0491876/Generic-Growth-Strategies---Manufacturers-to-Increase-Focus-on-Super-Generics-and-Biosimilars-to-Drive-Revenues.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Vitamin_and_Supplement Generic ...
Cached Medicine Technology:GT Life Sciences Broadens Intellectual Property Portfolio with Issuance of U.S. Patent on Core Computational Systems and Methods for Genomic-based Metabolic Modeling 2GT Life Sciences Broadens Intellectual Property Portfolio with Issuance of U.S. Patent on Core Computational Systems and Methods for Genomic-based Metabolic Modeling 3Reportlinker Adds Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues 2Reportlinker Adds Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues 3Reportlinker Adds Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues 4Reportlinker Adds Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues 5Reportlinker Adds Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues 6Reportlinker Adds Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues 7
Due to its thick formula, REFRESH CELLUVISC Lubricant Eye Drops is ideal for persistent dry eye conditions. REFRESH CELLUVISC provides lasting relief and protection for dry, scratchy eyes....
... solution is an anti-infective prescription ... may instruct you to use ... infection caused by bacteria. Bacterial ... the 2 types of eye ...
ALPHAGAN® (brimonidine tartrate ophthalmic solution) 0.2% is indicated for lowering IOP in patients with open-angle galucoma or ocular hypertension....
ALPHAGAN® (brimonidine tartrate ophthalmic solution) 0.2% is indicated for lowering IOP in patients with open-angle galucoma or ocular hypertension....
Medicine Products: